VENOUS THROMBOSIS

Type: Keyphrase
Name: VENOUS THROMBOSIS
First reported Oct 21 2014 - Updated Oct 21 2014 - 1 reports

Pregnancy Complications in Women With Heart Disease Conceiving With Fertility Therapy

A growing number of women seek infertility treatment with assisted reproductive technologies (ART), such as in vitro fertilization (IVF) or intrauterine insemination (IUI), in conjunction with ovarian stimulation treatments (1) . Although ART improve ... [Published Journal of the American College of Cardiology - Oct 21 2014]
First reported Oct 14 2014 - Updated Oct 14 2014 - 1 reports

1 person dies every 37 seconds from deep vein blood clot

MANILA, Philippines – Did you know that you could increase your risk of suffering from blood clot just by sitting on your office chair, in a car or a train?Based from the calculation extrapolated from the number of thrombosis-related deaths across Europe, ... [Published Philippine Star - Oct 14 2014]
First reported Oct 13 2014 - Updated Oct 13 2014 - 1 reports

Novartis MS pill heads stream of SMC approvals

Scottish patients with a severe form of relapsing remitting multiple sclerosis will become the first in the UK to get routine access to Novartis’ once daily pill Gilenya (fingolimod).The Scottish Medicines Consortium has become the first UK body to endorse ... [Published Pharma Times - Oct 13 2014]
First reported Oct 13 2014 - Updated Oct 13 2014 - 1 reports

Global Clot Management Devices Market Analysis and Forecast to 2020

New York, NY -- ( ReleaseWire ) -- 10/13/2014 -- Blood clot leads to blockage of blood supply to the heart, legs, brain and lungs. Blood clots develop in the arteries and causes diseases such as stroke, heart attack and sever legs pain. In addition, formation ... [Published SBWire - Oct 13 2014]
First reported Oct 13 2014 - Updated Oct 13 2014 - 1 reports

Venous thromboembolism in the elderly: efficacy and safety of non-VKA oral anticoagulants

Increasing age and renal impairment are risk factors for venous thrombosis but also for anticoagulant-induced bleeding. In large-scale phase III trials, non-VKA oral anticoagulants (NOACs) were at least as effective and safe for the treatment of acute ... [Published 7thSpace - Oct 13 2014]
First reported Oct 09 2014 - Updated Oct 09 2014 - 1 reports

Global Clot Management Devices Market Analysis and Forecast to 2020

Blood clot leads to blockage of blood supply to the heart, legs, brain and lungs. Blood clots develop in the arteries and causes diseases such as stroke, heart attack and sever legs pain. In addition, formation of blood clot is also a leading cause of ... [Published MyNewsDesk - Oct 09 2014]
First reported Oct 08 2014 - Updated Oct 08 2014 - 1 reports

NSAID users see an increased risk of venous thrombosis, study shows

Source: Dr Gladden Willis / Visuals Unlimited, Inc / Science Photo LibraryRisk of venous thrombosis was increased for users of non-steroidal anti-inflammatory drugsSome non-steroidal anti-inflammatory drugs (NSAIDs) increase the risk of arterial thrombosis. ... [Published Pharmaceutical Journal - Oct 08 2014]
First reported Oct 02 2014 - Updated Oct 02 2014 - 1 reports

NSAIDS users see an increased risk of venous thrombosis, study shows

Source: Dr Gladden Willis / Visuals Unlimited, Inc / Science Photo LibraryRisk of venous thrombosis was increased for users of non-steroidal anti-inflammatory drugsSome non-steroidal anti-inflammatory drugs (NSAIDs) increase the risk of arterial thrombosis. ... [Published Pharmaceutical Journal - Oct 02 2014]
First reported Oct 01 2014 - Updated Oct 01 2014 - 1 reports

Aspirin an effective alternative to anticoagulants: study

Low dose aspirin lowers the occurrence of new venous blood clots – and represents a reasonable treatment option for patients who are not candidates for long-term anticoagulant drugs, such as warfarin, according to a new study."The study [published by ... [Published Medical Search - Oct 01 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 1 reports

More than a pain: NSAIDs may raise VTE risk

Non-steroidal anti-inflammatory drugs (NSAIDs) may be good for what hurts, but they also could be setting patients up for pulmonary embolism. Venous thromboembolism (VTE) risk was increased in patients on NSAIDs, according to a study published Sept. 29 ... [Published Cardiovascular Business - Sep 29 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 1 reports

Genome-Wide Investigation of DNA Methylation Marks Associated with FV Leiden Mutation

by Dylan Aïssi, Jessica Dennis, Martin Ladouceur, Vinh Truong, Nora Zwingerman, Ares Rocanin-Arjo, Marine Germain, Tara A. Paton, Pierre-Emmanuel Morange, France Gagnon, David-Alexandre TrégouëtIn order to investigate whether DNA methylation marks could ... [Published Plosone.org - Sep 29 2014]
First reported Sep 26 2014 - Updated Sep 27 2014 - 1 reports

FDA Warns of Small Cardio, Cerebrovascular Risk With Xolair

A safety study conducted by the manufacturer of the asthma drug omalizumab ( Xolair , Genentech) suggests it poses a slightly elevated but serious risk for heart attacks and ministrokes known as transient ischemic attacks, the US Food and Drug Administration ... [Published American Journal of Public Health - Sep 26 2014]

Quotes

"in the formula, R sup.1 and R sup.2 are simultaneously or individually each a hydrogen atom, a halogen atom, a trifluoromethyl group a lower alkyl groupgroup a lower alkoxy group or a nitro group, and R sup.3 is a hydrogen atom, a halogen atom or a lower alkyl group, or a pharmacologically acceptable salt thereof as an active ingredient, and the pharmaceutical being administered in combination with an anti-VEGF agent."

More Content

All (30) | News (26) | Reports (0) | Blogs (4) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Patent Application Titled "Medicinal Agent for ... [Published 4 Traders - Oct 22 2014]
Hormonal Contraceptives: Prescribing, Complianc... [Published General Medicine eJournal - Oct 22 2014]
Pregnancy Complications in Women With Heart Dis... [Published Journal of the American College of Cardiology - Oct 21 2014]
1 person dies every 37 seconds from deep vein b... [Published Philippine Star - Oct 14 2014]
Novartis MS pill heads stream of SMC approvals [Published Pharma Times - Oct 13 2014]
Myeloproliferative Neoplasms [Published Cancernetwork.com - Oct 13 2014]
Global Clot Management Devices Market Analysis ... [Published SBWire - Oct 13 2014]
Venous thromboembolism in the elderly: efficacy... [Published 7thSpace - Oct 13 2014]
Bayer Supports World Thrombosis Day as Founding... [Published Bayer - Oct 13 2014]
Venous (Vein) Thrombosis Therapeutics Clinical ... [Published BioSpace - Oct 10 2014]
Momenta Pharmaceuticals Announces Top-Line Part... [Published BioSpace - Oct 09 2014]
Global Clot Management Devices Market Analysis ... [Published MyNewsDesk - Oct 09 2014]
NSAID users see an increased risk of venous thr... [Published Pharmaceutical Journal - Oct 08 2014]
NSAIDS users see an increased risk of venous th... [Published Pharmaceutical Journal - Oct 02 2014]
Aspirin an effective alternative to anticoagula... [Published Medical Search - Oct 01 2014]
Anterior Sacroiliac Dislocation: A Case Report ... [Published Journal of Bone and Joint Surgery - Sep 30 2014]
More than a pain: NSAIDs may raise VTE risk [Published Cardiovascular Business - Sep 29 2014]
Genome-Wide Investigation of DNA Methylation Ma... [Published Plosone.org - Sep 29 2014]
FDA Warns of Small Cardio, Cerebrovascular Risk... [Published American Journal of Public Health - Sep 26 2014]
Totally Implantable Venous Access Devices [Published General Medicine eJournal - Sep 25 2014]
Treatment of stroke using isolated placental cells [Published PharmCast - Sep 23 2014]
Testosterone Replacement Therapy Discussed by P... [Published PRWeb - Aug 27 2014]
Neurology Practice heads to Sun City West and t... [Published PRWeb - Aug 24 2014]
Bluegrass Vascular scores $4.5 mln Series A [Published PE Hub Blog - Jul 30 2014]
Payment and Delivery Reform Case Study: Cancer ... [Published Brookings Latest From Brookings - Jul 07 2014]
Momenta Pharmaceuticals Receives Orphan Drug De... [Published GlobeNewswire - Jun 05 2014]
Isis Pharmaceuticals Reports Positive Phase 2 D... [Published PR Newswire: Health - May 22 2014]
GMO Vaccine-Strain Measles vs Cancer [erv] [Published ScienceBlogs : Combined Feed - May 16 2014]
JTB Law Group Commences TVM Lawsuit as FDA Prop... [Published PRWeb - Apr 30 2014]
US FDA accepts Regado Biosciences' investigatio... [Published PharmaBiz - Feb 18 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Bluegrass Vascular scores $4.5 mln Series A [Published PE Hub Blog - Jul 30 2014]
Bluegrass Vascular Technologies said Wednesday that it has raised $4.5 million in Series A financing. Targeted Technology Fund II led the round. Based in Lexington, Kentucky, Bluegrass Vascular is a medical tech firm focused on developing methods ...
Payment and Delivery Reform Case Study: Cancer ... [Published Brookings Latest From Brookings - Jul 07 2014]
Editor’s note: This post is adapted from a forthcoming full-length case study; the second in a series from the Engelberg Center’s Merkin Initiative on Physician Payment Reform and Clinical Leadership designed to support clinician leadership of health ...
Isis Pharmaceuticals Reports Positive Phase 2 D... [Published PR Newswire: Health - May 22 2014]
CARLSBAD, Calif., May 22, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today positive top-line data from a Phase 2 comparator-controlled study evaluating the incidence of venous thrombolic events (VTE) in patients treated ...
GMO Vaccine-Strain Measles vs Cancer [erv] [Published ScienceBlogs : Combined Feed - May 16 2014]
So scientists cured a woman of a pervasive, treatment resistant  multiple myeloma . With a genetically modified, vaccine strain measles virus. Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy *anti-vax-anti-GMOers-heads-explode* ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.